Urology · Lynchburg, VA
NPI
1316157761
Since 2007
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2542 Langhorne Rd
Lynchburg, VA, 24501
Phone (434) 200-5297
Groups this clinician bills Medicare through
Medicare paid, 2024
$251K
5,097 services
Medicare patients, 2024
938
Average age 76
Drug cost, 2024
$322K
2,319 prescriptions
Company payments, 2023
$15.1
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Corey Passman was code 99214 (office e&m - established), 769 times for 511 patients. In total Corey Passman billed 5,097 services in 71 codes, and Medicare paid $251K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 769 | 511 | $90.04 | $69K |
| 81015 Clinical Chemistry | Office | 645 | 469 | $2.97 | $1,918 |
| 99213 Office E&M - Established | Office | 314 | 264 | $61.49 | $19K |
| 36415 Venipuncture Blood Collection | Office | 301 | 223 | $5.86 | $1,764 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 294 | 32 | $137.38 | $40K |
| 74018 Standard X-ray | Office | 175 | 132 | $21.37 | $3,739 |
| 52000 Cystourethroscopy | Facility | 173 | 138 | $54.60 | $9,446 |
| 51798 Ultrasound - Nonspecific | Office | 168 | 122 | $8.29 | $1,393 |
| 51702 Other Organ Systems | Office | 134 | 28 | $39.33 | $5,271 |
| 74420 Standard X-ray | Facility | 105 | 72 | $19.26 | $2,022 |
| 96402 Chemotherapy Administration | Office | 53 | 32 | $28.13 | $1,491 |
| 52356 Calculus Removal - Urinary | Facility | 48 | 43 | $319.38 | $15K |
| 52332 Cystourethroscopy | Facility | 43 | 36 | $112.34 | $4,830 |
| 99203 Office E&M - New | Office | 36 | 36 | $81.54 | $2,936 |
| 99212 Office E&M - Established | Office | 35 | 35 | $37.46 | $1,311 |
By year: 2022 $168K for 2,859 services; 2023 $228K for 4,593 services; 2024 $251K for 5,097 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81015 Clinical Chemistry | 645 | 469 | $2.97 | $1,918 |
| 36415 Venipuncture Blood Collection | 301 | 223 | $5.86 | $1,764 |
Medicare prescription drug claims, 2024
In 2024, the drug Corey Passman prescribed most often to Medicare patients was Tamsulosin Hcl, with 579 prescriptions and refills. In total Corey Passman wrote 2,319 Medicare prescriptions that cost $322K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 579 | 1,520 | 179 | $7,036 |
| Finasteride Generic | 554 | 1,484 | 158 | $6,740 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 344 | 789 | 103 | $6,821 |
| Cephalexin Generic | 107 | 115 | 79 | $721 |
| Trimethoprim Generic | 79 | 98 | 21 | $3,082 |
| Solifenacin Succinate Generic | 68 | 144 | 28 | $2,488 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 68 | 68 | 60 | $450 |
| Dutasteride Generic | 53 | 151 | 22 | $1,773 |
| Myrbetriq Mirabegron | 44 | 54 | Under 11 | $24K |
| Amoxicillin Generic | 38 | 38 | 27 | $106 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 37 | 43 | 31 | $160 |
| Methenamine Hippurate Generic | 35 | 63 | 13 | $2,888 |
| Silodosin Generic | 29 | 41 | Under 11 | $2,030 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 28 | 42 | Under 11 | $1,263 |
| Bicalutamide Generic | 22 | 22 | 11 | $305 |
Brand drugs: 144 claims; generic drugs: 2,175 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Corey Passman $15.1 ($15.1 in general payments such as food, travel and fees) from 1 company. The largest payer was Teleflex LLC with $15.1.
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC TFX | 1 | $15.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.